Fundraising Fox

Herantis Pharma

Founded 2008 · 25 employees on LinkedIn · 2 known investors

Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.

BiotechDeep TechMedical Devices

Founders & leadership

AV
Antti VuolantoCEO

Investors · 2

Broadview VenturesBoston
Innovestor VenturesHelsinki · $270K – $3.2M

In the news

Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096manilatimes.net · Jun 2026Herantis Pharma releases 2H and FY 2025 report today - BioSpacebiospace.com · Mar 2026Funding boost for promising treatment | Parkinson's UKparkinsons.org.uk · Feb 2026Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 - BioSpacebiospace.com · Feb 2026Herantis Pharma raises EUR 5.2 million - NLSnordiclifescience.org · Feb 2025

Frequently asked questions

What does Herantis Pharma do?
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
Who are Herantis Pharma's investors?
Herantis Pharma's investors include Broadview Ventures, Innovestor Ventures.